180 related articles for article (PubMed ID: 34015330)
1. The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi.
Ury B; Potelle S; Caligiore F; Whorton MR; Bommer GT
J Biol Chem; 2021; 296():100789. PubMed ID: 34015330
[TBL] [Abstract][Full Text] [Related]
2. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.
Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ
Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652
[TBL] [Abstract][Full Text] [Related]
3. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan.
Gerin I; Ury B; Breloy I; Bouchet-Seraphin C; Bolsée J; Halbout M; Graff J; Vertommen D; Muccioli GG; Seta N; Cuisset JM; Dabaj I; Quijano-Roy S; Grahn A; Van Schaftingen E; Bommer GT
Nat Commun; 2016 May; 7():11534. PubMed ID: 27194101
[TBL] [Abstract][Full Text] [Related]
4. A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2.
Li D; Mukhopadhyay S
J Biol Chem; 2021 Sep; 297(3):101069. PubMed ID: 34384782
[TBL] [Abstract][Full Text] [Related]
5. Novel Insights into Selected Disease-Causing Mutations within the
Szulc B; Zadorozhna Y; Olczak M; Wiertelak W; Maszczak-Seneczko D
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396746
[TBL] [Abstract][Full Text] [Related]
6. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan.
Imae R; Manya H; Tsumoto H; Miura Y; Endo T
J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834
[TBL] [Abstract][Full Text] [Related]
7. A functional splice variant of the human Golgi CMP-sialic acid transporter.
Salinas-Marín R; Mollicone R; Martínez-Duncker I
Glycoconj J; 2016 Dec; 33(6):897-906. PubMed ID: 27387429
[TBL] [Abstract][Full Text] [Related]
8. Cytidine Diphosphate-Ribitol Analysis for Diagnostics and Treatment Monitoring of Cytidine Diphosphate-l-Ribitol Pyrophosphorylase A Muscular Dystrophy.
van Tol W; van Scherpenzeel M; Alsady M; Riemersma M; Hermans E; Kragt E; Tasca G; Kamsteeg EJ; Pennings M; van Beusekom E; Vermeulen JR; van Bokhoven H; Voermans NC; Willemsen MA; Ashikov A; Lefeber DJ
Clin Chem; 2019 Oct; 65(10):1295-1306. PubMed ID: 31375477
[TBL] [Abstract][Full Text] [Related]
9. Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.
Ng BG; Asteggiano CG; Kircher M; Buckingham KJ; Raymond K; Nickerson DA; Shendure J; Bamshad MJ; ; Ensslen M; Freeze HH
Am J Med Genet A; 2017 Nov; 173(11):2906-2911. PubMed ID: 28856833
[TBL] [Abstract][Full Text] [Related]
10. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals.
Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T
J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide-sugar transporters: structure, function and roles in vivo.
Handford M; Rodriguez-Furlán C; Orellana A
Braz J Med Biol Res; 2006 Sep; 39(9):1149-58. PubMed ID: 16981043
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory machinery for the functional dystroglycan glycosylation.
Kondo Y; Okajima T
J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122
[TBL] [Abstract][Full Text] [Related]
13. Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver.
Ma X; Li Y; Kondo Y; Shi H; Han J; Jiang Y; Bai X; Archer-Hartmann SA; Azadi P; Ruan C; Fu J; Xia L
Haematologica; 2021 Mar; 106(3):759-769. PubMed ID: 32303557
[TBL] [Abstract][Full Text] [Related]
14. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
15. An insight into the orphan nucleotide sugar transporter SLC35A4.
Sosicka P; Maszczak-Seneczko D; Bazan B; Shauchuk Y; Kaczmarek B; Olczak M
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):825-838. PubMed ID: 28167211
[TBL] [Abstract][Full Text] [Related]
16. CDP-glycerol inhibits the synthesis of the functional
Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
[TBL] [Abstract][Full Text] [Related]
17. An interaction between SLC35A1 and ST3Gal4 is differentially affected by CDG-causing mutations in the SLC35A1 gene.
Wiertelak W; Olczak M; Maszczak-Seneczko D
Biochem Biophys Res Commun; 2022 Dec; 635():46-51. PubMed ID: 36257191
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the delivery of activated sialic acid into Golgi for sialyation.
Nji E; Gulati A; Qureshi AA; Coincon M; Drew D
Nat Struct Mol Biol; 2019 Jun; 26(6):415-423. PubMed ID: 31133698
[TBL] [Abstract][Full Text] [Related]
19. ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice.
Cataldi MP; Blaeser A; Lu P; Leroy V; Lu QL
Mol Ther Methods Clin Dev; 2020 Jun; 17():271-280. PubMed ID: 31988979
[TBL] [Abstract][Full Text] [Related]
20. Intellectual disability and bleeding diathesis due to deficient CMP--sialic acid transport.
Mohamed M; Ashikov A; Guillard M; Robben JH; Schmidt S; van den Heuvel B; de Brouwer AP; Gerardy-Schahn R; Deen PM; Wevers RA; Lefeber DJ; Morava E
Neurology; 2013 Aug; 81(7):681-7. PubMed ID: 23873973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
